MSB 5.24% $1.11 mesoblast limited

By October, the company should have the Back trial recruiting...

  1. 4,164 Posts.
    lightbulb Created with Sketch. 5428
    By October, the company should have the Back trial recruiting and running, and the GvHD adult trial up and running.

    Assuming the other 4 applications all result in more trials required, and pediatric GVHD' s is rejected, which is the worst possible outcome in my opinion, mid 2025 we should have an idea if the trials are not able to make the end points or not.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.